128 related articles for article (PubMed ID: 38215823)
21. Geographic access to buprenorphine prescribers for patients who use public transit.
Drake C; Donohue JM; Nagy D; Mair C; Kraemer KL; Wallace DJ
J Subst Abuse Treat; 2020 Oct; 117():108093. PubMed ID: 32811632
[TBL] [Abstract][Full Text] [Related]
22. Mapping Rural and Urban Veterans' Spatial Access to Primary Care Following the MISSION Act.
Sullivan E; Zahnd WE; Zhu JM; Kenzie E; Patzel M; Davis M
J Gen Intern Med; 2022 Sep; 37(12):2941-2947. PubMed ID: 34981345
[TBL] [Abstract][Full Text] [Related]
23. Role of independent versus chain pharmacies in providing pharmacy access: a nationwide, individual-level geographic information systems analysis.
Hernandez I; Tang S; Morales J; Gabriel N; Patel N; Mathis WS; Guo J; Berenbrok LA
Health Aff Sch; 2023 Jul; 1(1):. PubMed ID: 37750164
[TBL] [Abstract][Full Text] [Related]
24. Challenging terrains: socio-spatial analysis of Primary Health Care Access Disparities in West Virginia.
Hong I; Wilson B; Gross T; Conley J; Powers T
Appl Spat Anal Policy; 2023; 16(1):141-161. PubMed ID: 35967757
[TBL] [Abstract][Full Text] [Related]
25. Factors associated with choice of pharmacy setting among DoD health care beneficiaries aged 65 years or older.
Linton A; Garber M; Fagan NK; Peterson M
J Manag Care Pharm; 2007 Oct; 13(8):677-86. PubMed ID: 17970605
[TBL] [Abstract][Full Text] [Related]
26. Disparities in Access to Opioid Treatment Programs and Office-Based Buprenorphine Treatment Across the Rural-Urban and Area Deprivation Continua: A US Nationwide Small Area Analysis.
Amiri S; McDonell MG; Denney JT; Buchwald D; Amram O
Value Health; 2021 Feb; 24(2):188-195. PubMed ID: 33518025
[TBL] [Abstract][Full Text] [Related]
27. Expanding access to HPV vaccination in South Carolina through community pharmacies: A geospatial analysis.
Zahnd WE; Harrison SE; Stephens HC; Messersmith AR; Brandt HM; Hastings TJ; Eberth JM
J Am Pharm Assoc (2003); 2020; 60(6):e153-e157. PubMed ID: 32580908
[TBL] [Abstract][Full Text] [Related]
28. Spatial access to buprenorphine-waivered prescribers in the HEALing communities study: Enhanced 2-step floating catchment area analyses in Massachusetts, Ohio, and Kentucky.
Shrestha S; Lindstrom MR; Harris D; Rock P; Srinivasan S; Pustz JC; Bayly R; Stopka TJ
J Subst Use Addict Treat; 2023 Jul; 150():209077. PubMed ID: 37211155
[TBL] [Abstract][Full Text] [Related]
29. Spatial accessibility and travel to pharmacy by type in the Detroit region.
Li X; Vojnovic I; Ligmann-Zielinska A
J Am Pharm Assoc (2003); 2024; 64(3):102052. PubMed ID: 38401841
[TBL] [Abstract][Full Text] [Related]
30. Impact of Pharmacists on Access to Vaccine Providers: A Geospatial Analysis.
Shah PD; Trogdon JG; Golden SD; Golin CE; Marciniak MW; Brewer NT
Milbank Q; 2018 Sep; 96(3):568-592. PubMed ID: 30203603
[TBL] [Abstract][Full Text] [Related]
31. The positive pharmacy care law: an area-level analysis of the relationship between community pharmacy distribution, urbanity and social deprivation in England.
Todd A; Copeland A; Husband A; Kasim A; Bambra C
BMJ Open; 2014 Aug; 4(8):e005764. PubMed ID: 25116456
[TBL] [Abstract][Full Text] [Related]
32. Geographical accessibility to community pharmacies by the elderly in metropolitan Lisbon.
Padeiro M
Res Social Adm Pharm; 2018 Jul; 14(7):653-662. PubMed ID: 28789923
[TBL] [Abstract][Full Text] [Related]
33. Geographic accessibility of community pharmacies in ontario.
Law MR; Dijkstra A; Douillard JA; Morgan SG
Healthc Policy; 2011 Feb; 6(3):36-46. PubMed ID: 22294990
[TBL] [Abstract][Full Text] [Related]
34. Pharmacy-level barriers to implementing expedited partner therapy in Baltimore, Maryland.
Qin JZ; Diniz CP; Coleman JS
Am J Obstet Gynecol; 2018 May; 218(5):504.e1-504.e6. PubMed ID: 29410060
[TBL] [Abstract][Full Text] [Related]
35. The availability of pharmacies in the United States: 2007-2015.
Qato DM; Zenk S; Wilder J; Harrington R; Gaskin D; Alexander GC
PLoS One; 2017; 12(8):e0183172. PubMed ID: 28813473
[TBL] [Abstract][Full Text] [Related]
36. Potential access and revealed access to pain management medications.
Lin SJ; Crawford SY; Warren Salmon J
Soc Sci Med; 2005 Apr; 60(8):1881-91. PubMed ID: 15686818
[TBL] [Abstract][Full Text] [Related]
37. Causes and consequences of rural pharmacy closures: a multi-case study.
Todd K; Westfall K; Doucette B; Ullrich F; Mueller K; ;
Rural Policy Brief; 2013 Aug; (2013 11):1-4. PubMed ID: 25399462
[TBL] [Abstract][Full Text] [Related]
38. Medication deserts: survey of neighborhood disparities in availability of prescription medications.
Amstislavski P; Matthews A; Sheffield S; Maroko AR; Weedon J
Int J Health Geogr; 2012 Nov; 11():48. PubMed ID: 23137192
[TBL] [Abstract][Full Text] [Related]
39. Community pharmacies as access points for addiction treatment.
Look KA; Kile M; Morgan K; Roberts A
Res Social Adm Pharm; 2019 Apr; 15(4):404-409. PubMed ID: 29909934
[TBL] [Abstract][Full Text] [Related]
40. Accessibility of Pharmacist-Prescribed Contraceptives in Utah.
Magnusson BM; Christensen SR; Tanner AB; Eyring JB; Pilling EB; Sloan-Aagard CD
Obstet Gynecol; 2021 Dec; 138(6):871-877. PubMed ID: 34735383
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
